Mr. Taylor (for himself and Ms. Schakowsky) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Drug-price Transparency for Consumers Act of 2025. H.R. 3789. 119th
Cong., 1st
sess., Introduced in House June 5, 2025. https://www.govinfo.gov/app/details/BILLS-119hr3789ih.
APA
Congress, House of Representatives (2025, June 5). Drug-price Transparency for Consumers Act of 2025 (H.R. 3789 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr3789ih.
MLA
United States, Congress, House of Representatives. Drug-price Transparency for Consumers Act of 2025. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr3789ih. 119th Congress, H.R. 3789, Introduced in House 5 Jun. 2025.
Bluebook
H.R.3789 - 119th Congress (2025-2026): Drug-price Transparency for Consumers Act of 2025, H.R.3789, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr3789ih.
